The current work aimed to investigate the whole blood GLUT1 mRNA expression and serum PEDF, IL-6, fetuin-A, and PTX3 levels in psoriatic patients and tested their correlations with the severity of psoriasis using the psoriasis area and severity index (PASI) score. The gene discussed is SLC2A1; the disease is psoriasis.